Anpac Bio Medical Stock Price To Earning
ANPCDelisted Stock | USD 4.37 0.20 4.38% |
Anpac Bio Medical fundamentals help investors to digest information that contributes to Anpac Bio's financial success or failures. It also enables traders to predict the movement of Anpac Stock. The fundamental analysis module provides a way to measure Anpac Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anpac Bio stock.
Anpac |
Anpac Bio Medical Company Price To Earning Analysis
Anpac Bio's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Anpac Bio Medical has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The price to earning for all United States stocks is 100.0% higher than that of the company.
Anpac Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anpac Bio's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics of similar companies.Anpac Bio is currently under evaluation in price to earning category among its peers.
Anpac Fundamentals
Return On Equity | -2.43 | |||
Return On Asset | -0.53 | |||
Operating Margin | (8.71) % | |||
Current Valuation | 9.28 M | |||
Shares Outstanding | 6.27 M | |||
Shares Owned By Insiders | 2.15 % | |||
Shares Owned By Institutions | 0.09 % | |||
Number Of Shares Shorted | 44.48 K | |||
Price To Book | 5.67 X | |||
Price To Sales | 0.41 X | |||
Revenue | 12.04 M | |||
Gross Profit | 12.25 M | |||
EBITDA | (78.4 M) | |||
Net Income | (103.6 M) | |||
Cash And Equivalents | 462 K | |||
Cash Per Share | 0.02 X | |||
Total Debt | 19.81 M | |||
Debt To Equity | 1.44 % | |||
Current Ratio | 0.39 X | |||
Book Value Per Share | 10.63 X | |||
Cash Flow From Operations | (55.06 M) | |||
Short Ratio | 2.50 X | |||
Earnings Per Share | (11.45) X | |||
Target Price | 8.0 | |||
Beta | 1.56 | |||
Market Capitalization | 27.41 M | |||
Total Asset | 40.47 M | |||
Retained Earnings | (577.54 M) | |||
Working Capital | (28.58 M) | |||
Current Asset | 23.44 M | |||
Current Liabilities | 68.22 M | |||
Z Score | -26.09 | |||
Net Asset | 40.47 M |
About Anpac Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anpac Bio Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Transaction History View history of all your transactions and understand their impact on performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |